Ultherapy Safety & Side Effects

Ultherapy carries FDA clearance since 2009 and KFDA approval for non-invasive lifting, with a serious adverse event rate below 0.1% across 3 million+ global treatments. Focused ultrasound reaches the SMAS layer at 4.5mm depth without breaking skin, triggering collagen renewal over 2-3 months. Common side effects include temporary redness and tenderness resolving within 24-72 hours.
Ultherapy Safety & Side Effects

Regulatory Clearance and Ultherapy Safety Record

Ultherapy received FDA 510(k) clearance in September 2009, becoming the first and only non-invasive procedure cleared specifically for lifting the skin on the neck, chin, and brow. In 2012, the FDA expanded clearance to include improvement of lines and wrinkles on the decolletage. The Korean Ministry of Food and Drug Safety (KFDA) granted parallel clearance, confirming that Ultherapy meets safety standards recognized across both Western and Asian regulatory systems.

With over 3 million treatments performed globally, the cumulative safety data shows a serious adverse event rate below 0.1%. The micro-focused ultrasound with visualization (MFU-V) technology allows practitioners to see tissue layers in real time on the device screen before delivering energy, adding a layer of precision that reduces off-target exposure.

How Ultherapy Works at the Tissue Level

Ultherapy delivers focused ultrasound energy to three specific depths: 1.5mm (dermis), 3.0mm (deep dermis), and 4.5mm (SMAS layer). The energy creates thermal coagulation points at temperatures between 60-70 degrees Celsius, triggering a wound-healing response that produces new collagen and elastin fibers over the following 90-180 days. The epidermis remains intact throughout the procedure because the focused beam bypasses the skin surface entirely.

Common Side Effects and Recovery Timeline

Immediate Effects (0-48 Hours)

Redness appears in approximately 85% of patients and resolves within 1-3 hours for most individuals. Mild swelling occurs in 20-35% of cases, particularly around the jawline and periorbital area, fading completely within 24-48 hours. Temporary tingling or numbness in treated zones affects roughly 10-15% of patients and normalizes within the first week. These reactions scale with the number of treatment lines delivered during the session.

Rare and Serious Adverse Events

Bruising occurs in fewer than 5% of treatments and resolves within 7-10 days without intervention. Temporary nerve paresis, presenting as slight weakness in facial muscles, has been documented at a rate below 0.5% and resolves spontaneously within 2-6 weeks. Burns or blistering remain exceedingly rare at under 0.05% incidence when the device is operated according to manufacturer protocols with proper contact and coupling gel application.

Contraindications and Who Should Avoid Ultherapy

Ultherapy is contraindicated for individuals with active skin infections, open wounds, or cystic acne in the target treatment area. Patients with metallic implants such as dental braces or metal plates in the face require assessment, as ultrasound energy may interact with metal surfaces. Isotretinoin use within the past 6 months increases skin sensitivity and healing variability, requiring medical clearance before proceeding with any energy-based treatment.

Pregnancy and breastfeeding represent absolute contraindications due to the absence of safety data in these populations. Individuals with bleeding disorders or those taking anticoagulant medications face elevated bruising risk. Unlike some laser treatments, Ultherapy treats all Fitzpatrick skin types I through VI because ultrasound energy bypasses melanin in the epidermis, making it suitable for a broad range of skin tones without hyperpigmentation risk.

Clinical Evidence for Ultherapy Safety

A pivotal study evaluating 103 subjects receiving Ultherapy for brow lifting demonstrated measurable eyebrow elevation in 86% of participants at 90 days post-treatment, with no serious adverse events recorded during the 180-day follow-up period. Alam M et al. Dermatol Surg. 2010;36(12):2048-2055. doi:10.1111/j.1524-4725.2010.01810.x

Practitioners at RE:BERRY Gangnam follow standardized Ultherapy protocols with treatment line counts calibrated to each patient's facial anatomy and skin thickness, maintaining consistent safety margins across all sessions. Real-time ultrasound visualization confirms that energy targets the correct tissue layer before each pulse fires, reducing operator-dependent variability inherent in non-visualized energy delivery systems.

Frequently Asked Questions

Is Ultherapy safe for all skin types?
Ultherapy treats all 6 Fitzpatrick skin types (I-VI) without modification to energy settings or protocol. Focused ultrasound bypasses melanin in the epidermal layer entirely, reducing hyperpigmentation risk to below 0.1%. Patients with darker skin tones who face elevated risk from laser and light-based devices tolerate Ultherapy without additional precautions or post-treatment restrictions.
What are the side effects of Ultherapy?
Redness occurs in 85% of patients and fades within 1-3 hours post-treatment. Mild swelling affects 20-35% of cases, resolving within 48 hours. Tenderness in treated areas persists for 1-5 days in approximately 15-20% of patients. Bruising appears in fewer than 5% of treatments. Serious complications such as temporary nerve weakness occur at rates below 0.5%.
How do I know if a clinic is qualified?
3 verification steps confirm a qualified Ultherapy clinic: check the practitioner's manufacturer-issued Ultherapy certification, confirm the clinic holds a valid Korean medical institution registration, and ask to see the device serial number with current calibration records. Authorized clinics use genuine Merz Ultherapy systems with verified transducer counts and maintenance logs.
What certifications should I look for?
2 regulatory clearances validate Ultherapy device safety: FDA 510(k) clearance granted in 2009 and KFDA approval from Korea's Ministry of Food and Drug Safety. The treating physician should hold a Korean medical license and manufacturer-specific device training certification. Clinics should maintain documented treatment protocols and carry medical liability insurance.
Are there long-term risks?
180-day follow-up data from FDA pivotal studies show zero serious long-term adverse events among Ultherapy subjects. The focused ultrasound energy creates thermal points at controlled 60-70 degree temperatures that heal completely within the standard wound-response cycle. No cases of chronic scarring, permanent fat atrophy, or lasting nerve damage appear in peer-reviewed Ultherapy literature.
Can Ultherapy cause nerve damage?
Temporary nerve paresis occurs in fewer than 0.5% of Ultherapy treatments, presenting as slight muscle weakness in the treated area. Episodes resolve spontaneously within 2-6 weeks as nerve fibers recover from localized thermal exposure. Permanent nerve damage has not been documented in published clinical trials involving Ultherapy, largely because MFU-V visualization confirms targeting before energy delivery.
How does Ultherapy safety compare to surgical facelifts?
Surgical facelifts carry complication rates of 5-8% including infection, hematoma, and permanent scarring, compared to Ultherapy's serious adverse event rate below 0.1%. Recovery from surgery requires 2-4 weeks of downtime versus zero downtime for Ultherapy. Anesthesia-related risks are eliminated entirely since Ultherapy requires no sedation or general anesthesia for standard facial protocols.

Book a Consultation

Free consultation. We respond within 24 hours.

Thank you! We will contact you within 24 hours.